Pre-clinical pharmacology of zolmitriptan (Zomig™; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine (Q41661654)
scientific article published on October 1, 1997
Language:
(P31) (Q13442814)
(P304) 4-14
(P407) (Q1860)
(P478) 17 Suppl 18
(P577) Wednesday, October 1, 1997
Wednesday, October 1, 1997
(P921) (Q128406)
(P953) https://journals.sagepub.com/doi/pdf/10.1177/0333102497017S1802
(P1433) (Q5063251)
(P1476) "Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine" (language: en)
"Pre-clinical pharmacology of zolmitriptan (Zomig™; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine" (language: en)
(P2093) G. R. Martin
(P2860) (Q38004483)
(Q35234469)
(Q40494636)
(Q28265001)
(Q36771308)
(Q36419041)
(Q46169447)
(Q36130381)
(Q40947000)
(Q41140092)
(Q35026033)
(Q40645621)
(Q41533296)
(Q41099294)
(Q39409976)
(Q35756243)
(Q36723711)
(Q42707469)
(Q50919131)
(Q39461354)
(Q39569175)
(Q48715691)
(Q36329540)
(Q48744994)
(Q48896233)
(Q57025045)
(Q54394241)
(Q53361377)
(Q41951262)
(Q68252114)
(Q69028685)
(Q2085079)
(Q72835946)
(Q72019121)
(Q1943386)
(Q86856608)
(Q2160146)
(Q71815315)
(Q68096309)
(Q70870491)
(P13046) (Q7318358)
other details
description scientific article published on October 1, 1997

External Links